Finland· FI-REL-REL43616
Vimpat
A lacosamide product containing lacosamide, registered in Finland by Paranova Oy. The same ATC class is registered in 18 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Lacosamide is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AX18 (lacosamide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Lacosamide · ATC N03AX18
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lacosamide costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.48 in United States to $3.11 in Switzerland — a ×6.4 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Lacosamide · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$3.11
- IT Italy$3.06
- FR France$1.49
- US United States$0.48 (acquisition cost)
The record
At a glance
Fimea (Finland)- Active substance
- Lacosamide
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- N03AX18
- ATC class
- Lacosamide
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
62 interactions on record for lacosamide.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lacosamide · interactions on record
62 records
- 5 severe
- 32 moderate
Most severe, free to view
- DolasetronA04AA04severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
- SiponimodL04AA42severe
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lacosamide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaLACOSAMIDE ACCORDAccord Healthcare S.L.U., Barcelona
- SpainLACOSAMIDA ACCORD 10 MG/ML SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- SwedenLacosamide Accord 10 mg/ml Infusionsvätska, lösningAccord Healthcare S.L.U.
- PolandLacosamide AccordAccord Healthcare S.L.U.
- United StatesLACOSAMIDEAnthea Pharma Private Limited
- Ireland10 mg/ml Solution for infusionUCB Pharma S.A.
- BelgiumLacosamide Accord 10 mg/mlAccord Healthcare
- IcelandLacosamide AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Lacopat, Lacopat Packung Zur Behandlungseinleitung
- Belgium · Lacosamid Hikma, Lacosamide Eg
- Bulgaria · Канилад, Лакозамид Гриндекс
- Cyprus · Kanilad, Lacosadel
- Czechia · Arkvimma, Kanilad
- Germany · Kanilad, Lackepila
- Denmark · 200 mg, Lacosamid Opko Health Spain
- Estonia · Kanilad, Lacosamide Alembic
- Spain · Balmid, Kanilad
- France · Lacosamide Arrow, Lacosamide Biogaran
- United Kingdom (Northern Ireland) · Lacosamide, Lacosamide Amarox
- Greece · Anlamyl, Josamec
- Croatia · Kanilad, Lacosamide Grindeks
- Hungary · Anlamyl, Arkvimma
- Ireland · Lacosamide Ascend, Lacosamide Fresenius Kabi
- Iceland · Josamec, Lacosamide Accord
- Italy · Lacosamide Aurobindo, Lacosamide Doc
- Liechtenstein · Lacosamid Fresenius Kabi, Lacosamide Accord
- Lithuania · Lacosamide Fresenius Kabi, Lacosamide Grindeks
- Luxembourg · Lacosamide Eg
- Latvia · Kanilad, Lacosamide Fresenius Kabi
- Malta · Anlamyl, Kanilad
- Netherlands · Cosim, Lacosamide Amarox
- Norway · Lacosamide Accord, Lacosamide Fresenius Kabi
- Poland · Arkvimma, Epilantin
- Portugal · Lacosamida Alter, Lacosamida Aristo
- Romania · Lacosamidă Teva
- Sweden · Lacomed, Lacosamide 1a Farma
- Slovenia · Lacosabil, Lacosamide Grindeks
- Slovakia · Arkvimma, Kanilad
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b58a527e-b732-4005-a997-ea9a86f0f10d GET /v1/drugs/b58a527e-b732-4005-a997-ea9a86f0f10d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.3",
"form": "infuusioneste, liuos",
"route": "Laskimoon",
"ddd_unit": "g",
"strength": "10 mg/ml",
"atc_label": "lakosamidi",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/08/470/016",
"fimea_rel_id": "REL43616",
"authorised_at": "2013-03-22"
}See everything about lacosamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.